发明名称 |
Antagonister av den oncogeniske aktivitet av proteinet mdm2 samt anvendelsen derav ved behandling av cancer |
摘要 |
The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition. |
申请公布号 |
NO980905(A) |
申请公布日期 |
1998.03.02 |
申请号 |
NO19980000905 |
申请日期 |
1998.03.02 |
申请人 |
RHONE-POULENC RORER SA;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE |
发明人 |
TOCQUE, BRUNO;DUBS-POTERSZMAN, MARIE CHRISTINE;WASYLYK, BOHDAN |
分类号 |
C12N15/09;A61K31/00;A61K38/00;A61K45/00;A61P35/00;C07K14/47;C07K14/82;C07K16/00;C07K16/32;(IPC1-7):A61K45/00;A61K45/05;A61K38/17;C12N15/86 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|